Subtopic Deep Dive
Chronic Non-Cancer Pain Management Guidelines
Research Guide
What is Chronic Non-Cancer Pain Management Guidelines?
Chronic Non-Cancer Pain Management Guidelines provide evidence-based protocols for opioid prescribing in non-malignant chronic pain, focusing on risk assessment, multimodal therapies, and deprescribing to minimize addiction risks.
These guidelines emerged amid rising opioid prescriptions linked to the public health crisis. Key documents include ASIPP guidelines by Manchikanti (2017, 421 citations) and reviews by Cheung (2014, 86 citations) comparing treatment protocols. Over 20 papers from 2012-2019 address adherence, trends, and alternatives, with high-citation works exceeding 1,000 citations.
Why It Matters
Guidelines reduce iatrogenic opioid use disorder by stratifying patient risks and promoting non-opioid options, directly impacting public health outcomes. Kolodny et al. (2015, 1353 citations) highlight how high prescribing drove the epidemic, while Guy et al. (2017, 1076 citations) track reductions post-guideline implementation. Manchikanti (2017, 421 citations) provides safe prescribing standards adopted in interventional pain practices, balancing pain relief with overdose prevention as in Gaither et al. (2016, 266 citations).
Key Research Challenges
Guideline Adherence Variability
Primary care providers often deviate from protocols due to patient pressures and lack of training. Sekhon et al. (2013, 44 citations) found low compliance in Veterans Affairs settings. This leads to inconsistent risk stratification and monitoring.
Balancing Pain Relief and Risks
Guidelines emphasize multimodal therapy, but evidence gaps persist on long-term efficacy versus addiction. Cheung (2014, 86 citations) reviews paucity of strong data supporting chronic opioid therapy. Deprescribing protocols challenge providers amid patient dependence.
Population-Specific Adaptations
Mental health comorbidities increase opioid needs but heighten misuse risks. Davis et al. (2017, 276 citations) report this group receives over half of prescriptions. Pediatric and emergency settings require tailored rules, as in Cantrill et al. (2012, 241 citations).
Essential Papers
The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction
Andrew Kolodny, David T. Courtwright, Catherine S. Hwang et al. · 2015 · Annual Review of Public Health · 1.4K citations
Public health authorities have described, with growing alarm, an unprecedented increase in morbidity and mortality associated with use of opioid pain relievers (OPRs). Efforts to address the opioid...
Vital Signs: Changes in Opioid Prescribing in the United States, 2006–2015
Gery P. Guy, Kun Zhang, Michele K. Bohm et al. · 2017 · MMWR Morbidity and Mortality Weekly Report · 1.1K citations
Despite reductions in opioid prescribing in some parts of the country, the amount of opioids prescribed remains high relative to 1999 levels and varies substantially at the county-level. Given asso...
Responsible, Safe, and Effective Prescription ofOpioids for Chronic Non-Cancer Pain: AmericanSociety of Interventional Pain Physicians(ASIPP) Guidelines
Laxmaiah Manchikanti · 2017 · Pain Physician · 421 citations
The methodology utilized included the development of objectives and key questions. The methodology also utilized trustworthy standards, appropriate disclosures of conflicts of interest, as well as ...
Prescription Opioid Use among Adults with Mental Health Disorders in the United States
Matthew A. Davis, Lewei Lin, Haiyin Liu et al. · 2017 · The Journal of the American Board of Family Medicine · 276 citations
The 16% of Americans who have mental health disorders receive over half of all opioids prescribed in the United States. Improving pain management among this population is critical to reduce nationa...
National Trends in Hospitalizations for Opioid Poisonings Among Children and Adolescents, 1997 to 2012
Julie R. Gaither, John M. Leventhal, Sheryl A. Ryan et al. · 2016 · JAMA Pediatrics · 266 citations
During the course of 16 years, hospitalizations attributed to opioid poisonings rose nearly 2-fold in the pediatric population. Hospitalizations increased across all age groups, yet young children ...
Clinical Policy: Critical Issues in the Prescribing of Opioids for Adult Patients in the Emergency Department
Stephen V. Cantrill, Michael D. Brown, Russell J. Carlisle et al. · 2012 · Annals of Emergency Medicine · 241 citations
Trends in use and misuse of opioids in the Netherlands: a retrospective, multi-source database study
Gerard A. Kalkman, Cornelis Kramers, Robert T. van Dongen et al. · 2019 · The Lancet Public Health · 188 citations
Reading Guide
Foundational Papers
Start with Cantrill et al. (2012, 241 citations) for emergency prescribing policies and Cheung (2014, 86 citations) for chronic therapy guideline synthesis, establishing core protocols before recent trends.
Recent Advances
Study Manchikanti (2017, 421 citations) for ASIPP standards and Guy et al. (2017, 1076 citations) for U.S. prescribing changes post-guidelines.
Core Methods
Risk assessment via stratification tools, multimodal non-opioid integration, and compliance monitoring with urine tests (Manchikanti, 2017; Sekhon, 2013).
How PapersFlow Helps You Research Chronic Non-Cancer Pain Management Guidelines
Discover & Search
Research Agent uses searchPapers and citationGraph on 'ASIPP opioid guidelines Manchikanti' to map 421-citation paper connections to Kolodny et al. (2015), revealing epidemic context. exaSearch uncovers guideline adherence studies like Sekhon et al. (2013); findSimilarPapers expands to European trends in Kalkman et al. (2019).
Analyze & Verify
Analysis Agent applies readPaperContent to extract risk stratification from Manchikanti (2017), then verifyResponse with CoVe against GRADE criteria for weak chronic opioid evidence in Cheung (2014). runPythonAnalysis statistically verifies prescribing trends from Guy et al. (2017) data, grading recommendations as moderate quality.
Synthesize & Write
Synthesis Agent detects gaps in deprescribing protocols across papers, flagging contradictions between U.S. (Zhu et al., 2019) and European (Kalkman et al., 2019) trends. Writing Agent uses latexEditText, latexSyncCitations for guideline comparison tables, and latexCompile for exportable reports with exportMermaid flowcharts of multimodal therapy pathways.
Use Cases
"Analyze opioid prescribing trends in Guy et al. 2017 with statistics"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas on county-level data) → matplotlib trend plots and statistical significance tests output.
"Draft LaTeX review of ASIPP vs Washington State guidelines"
Research Agent → citationGraph → Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Manchikanti 2017, Neven 2012) → latexCompile PDF.
"Find code for opioid risk models from papers"
Research Agent → paperExtractUrls → Code Discovery → paperFindGithubRepo → githubRepoInspect → verified implementation of stratification algorithms.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ papers on guideline adherence, chaining searchPapers → citationGraph → GRADE grading for structured report on compliance gaps like Sekhon (2013). DeepScan applies 7-step analysis with CoVe checkpoints to verify multimodal therapy evidence from Manchikanti (2017). Theorizer generates hypotheses on deprescribing protocols from trend data in Guy et al. (2017).
Frequently Asked Questions
What defines Chronic Non-Cancer Pain Management Guidelines?
Protocols for safe opioid use in non-malignant pain, including risk stratification and alternatives (Manchikanti, 2017).
What are key methods in these guidelines?
Multimodal therapy, urine monitoring, and deprescribing; ASIPP uses expert panels and conflict disclosures (Manchikanti, 2017).
What are seminal papers?
Manchikanti (2017, 421 citations) for ASIPP guidelines; Kolodny et al. (2015, 1353 citations) for crisis context; Cheung (2014, 86 citations) for guideline comparison.
What open problems exist?
Low adherence in primary care (Sekhon et al., 2013); adapting for mental health patients (Davis et al., 2017); long-term efficacy data gaps (Cheung, 2014).
Research Opioid Use Disorder Treatment with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Chronic Non-Cancer Pain Management Guidelines with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Opioid Use Disorder Treatment Research Guide